This module provides a comprehensive overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), covering pathophysiology (basic level), epidemiology, natural histology, and screening/diagnosis using non-invasive tests. Through lectures and hands-on workshops, participants will gain the practical skills necessary for interpreting non-invasive tests, performing liver elastography, and designing screening pathways to optimize the management of patients with MASLD.

Academy Organisers: Jérôme Boursier

Please note that the programme is subject to change, and will be updated continuously up to the event.

• To learn the basics of the pathophysiology of MASLD.
• To understand the rationale for screening at-risk patients in MASLD.
• To gain comprehensive knowledge of the different non-invasive tests available.
• To know how to use non-invasive tests to accurately identify at-risk patients.

• Learn the basics of the pathophysiology of MASLD.
• Understand the rationale for screening in light of the epidemiology and natural history of MASLD.
• Gain knowledge of non-invasive tests for screening, diagnosis, risk stratification, and correct interpretation.
• Acquire competence in measuring liver stiffness using elastography devices through practical workshop.
• Develop practical strategies to implement a screening pathway within your professional network.

• Learn from expert faculty and gain insight into evidence-based MASLD management.
• Acquire hands-on experience with elastography devices and practical MASLD assessment tools.
• Network with peers and faculty to discuss case-based approaches and challenges in MASLD care.

• Hepatogastroenterologists interested in MASLD.
• Internists and primary care physicians involved in liver disease screening.
• Stakeholders and healthcare professionals involved in metabolic and liver disease management.